COc1ccc(C(C(=O)NC2CCCC2)N(C(=O)c2ccco2)c2cccc(C(C)=O)c2)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?